Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics (Q44763087)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics |
scientific article published in April 2004 |
Statements
1 reference
Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokinetics (English)
1 reference
Alexander M M Eggermont
1 reference
Peter Brouckaert
1 reference
Nozomi Takahashi
1 reference
Sandra T van Tiel
1 reference
Jeroen Hostens
1 reference
Ann L B Seynhaeve
1 reference
Walter Fiers
1 reference
Timo L M ten Hagen
1 reference
1 April 2004
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference